Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

NCT02368665 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

NCT00573742 ·Status: COMPLETED

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

NCT00434967 ·Status: COMPLETED ·Phase: PHASE3

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

NCT01012479 ·Status: COMPLETED ·Phase: PHASE4

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

NCT00348686 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

NCT01611077 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

NCT01289132 ·Status: COMPLETED ·Phase: PHASE2

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

NCT00679640 ·Status: COMPLETED

Azilsartan Tablets Special Drug Use Surveillance: Long-term Use

NCT02092025 ·Status: COMPLETED

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

NCT03847506 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

NCT02548286 ·Status: COMPLETED ·Phase: PHASE1

Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil

NCT02047019 ·Status: WITHDRAWN ·Phase: PHASE3

CKD-330 Drug-Drug Interaction Study (Candesartan)

NCT02064621 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

NCT01788358 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

NCT02094924 ·Status: COMPLETED ·Phase: PHASE1

Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"

NCT02166697 ·Status: COMPLETED

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

NCT01303783 ·Status: COMPLETED ·Phase: PHASE2

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

NCT01613209 ·Status: COMPLETED ·Phase: PHASE3

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

NCT00282178 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

NCT02521233 ·Status: WITHDRAWN ·Phase: PHASE3

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

NCT02006589 ·Status: COMPLETED ·Phase: PHASE1

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

NCT00716950 ·Status: UNKNOWN ·Phase: PHASE4

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

NCT00108706 ·Status: UNKNOWN ·Phase: PHASE4